Acute monoblastic leukemia

From Medicine GPT
Revision as of 04:28, 12 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Acute Monoblastic Leukemia (pronunciation: a-kyoot mon-o-blas-tik loo-kee-mee-a) is a subtype of Acute Myeloid Leukemia (AML) characterized by the presence of more than 80% monoblasts in the bone marrow.

Etymology

The term "Acute Monoblastic Leukemia" is derived from the Greek words "akutos" (meaning sharp or sudden), "mono" (meaning single), "blastos" (meaning germ or sprout), and "leukos" (meaning white). The term "leukemia" is derived from the Greek words "leukos" and "haima" (meaning blood).

Definition

Acute Monoblastic Leukemia is a type of cancer that starts in the blood-forming cells of the bone marrow. In this type of leukemia, the bone marrow makes too many immature white blood cells called monoblasts, which crowd out the healthy cells.

Symptoms

Symptoms of Acute Monoblastic Leukemia may include fatigue, fever, weight loss, and frequent infections due to the lack of healthy blood cells.

Diagnosis

Diagnosis of Acute Monoblastic Leukemia is typically made through a bone marrow biopsy, where a small sample of bone marrow is removed and examined under a microscope.

Treatment

Treatment for Acute Monoblastic Leukemia typically involves chemotherapy, and in some cases, a stem cell transplant may be recommended.

Prognosis

The prognosis for Acute Monoblastic Leukemia varies depending on a number of factors, including the patient's age and overall health.

Related Terms

External links

Esculaap.svg

This MedicineGPT article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski